Description
OMNICLAV 625 Tablet is a combination antibiotic manufactured by Cipla Ltd., containing Amoxicillin 500 mg and Potassium Clavulanate 125 mg. This formulation is designed to combat bacterial infections more effectively by enhancing the action of Amoxicillin against beta-lactamase producing bacteria.
-
Amoxicillin works by inhibiting bacterial cell wall synthesis, killing susceptible bacteria.
-
Potassium Clavulanate protects Amoxicillin from degradation by beta-lactamase enzymes, ensuring broader antibacterial coverage.
This combination is highly effective for treating respiratory, urinary, skin, and soft tissue infections, and other bacterial infections.
Uses:
-
Respiratory tract infections: Bronchitis, pneumonia, tonsillitis, pharyngitis, sinusitis
-
Ear, nose, and throat infections
-
Urinary tract infections (UTIs)
-
Skin and soft tissue infections
-
Dental infections
Key Benefits:
-
Broad-spectrum antibiotic effective against beta-lactamase producing bacteria
-
Provides relief from fever, pain, swelling, and redness caused by bacterial infections
-
Prevents recurrence and spread of infection
-
Trusted quality from Cipla Ltd.
How to Take:
-
Take as prescribed by your doctor
-
Swallow the tablet whole with water, preferably after meals
-
Complete the full prescribed course, even if symptoms improve early
Precautions:
-
Not effective against viral infections like cold or flu
-
Inform your doctor if allergic to penicillins or clavulanate
-
Use with caution in patients with kidney or liver disease
-
Pregnant or breastfeeding women should take only if advised by a doctor
Possible Side Effects:
-
Common: Nausea, vomiting, diarrhea, mild rash, stomach discomfort
-
Rare but serious: Severe allergic reactions, persistent diarrhea (C. difficile infection)
Storage:
-
Store in a cool, dry place below 25°C
-
Keep out of reach of children and away from direct sunlight
Leave a Reply